Publication Name	World Journal of Methodology
Manuscript ID	100074
Country	Qatar

Category	Cell & Tissue Engineering
Manuscript Type	Letter to the Editor
Article Title	Evaluating Wharton’s jelly-derived stem cell therapy in autism: Insights from a case study
Manuscript Source	Invited Manuscript
All Author List	Muzamil Akhtar and Abdulqadir J Nashwan
Funding Agency and Grant Number
Corresponding Author	Abdulqadir J Nashwan, MSc, PhD, Research Scientist, Department of Nursing and Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa
Key Words	Autism spectrum disorder; Stem cell therapy; Neuroinflammation; Neurodevelopmental disorders; Wharton jelly derived mesenchymal stem cell
Core Tip	This letter highlights the groundbreaking study by Kabatas et al, which demonstrates the efficacy and safety of Wharton’s jelly-derived mesenchymal stem cell (WJ-MSC) therapy in improving developmental outcomes for a child with autism spectrum disorder. Despite limitations such as the single-case design and lack of a control group, the study suggests WJ-MSC therapy as a promising treatment option, emphasizing the need for larger, controlled trials to validate these findings and develop standardized treatment protocols.
Citation	Akhtar M, Nashwan AJ. Evaluating Wharton’s jelly-derived stem cell therapy in autism: Insights from a case study. World J Methodol 2024; In press

Received	2024-08-22 08:29
Peer-Review Started	2024-08-06 11:19
To Make the First Decision
Return for Revision	2024-09-19 02:04
Revised	2024-09-26 20:48
Second Decision	2024-09-29 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-30 07:37
Articles in Press	2024-09-30 07:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com